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Abstract. 1. Three cases of acute rejection were detected by
macrophage migration inhibition tests (MIT) conducted directly on
seven patients who had received renal allografts. The macrophage
migration inhibitory factor (MIF) activity was positive in all cases 1-2
days before the appearance of acute rejection. 2. After the adminis-
tration of a high dose of Solu-Medrol (1 gjday for 3 days) to suppress
the acute rejection, MIF activity recovered to its normalleve1 3 days
later. These findings seem to indicate that MIT yields immunolog-
ically useful criteria for the early detection of an acute rejection.
Early detection of acute renal allograft rejection is an important problem for
improving the functional survival of transplanted kidneys in our clinical practice.
The chemical tests of blood and urine that are now used in clinics can detect the
acute rejection reaction only when the disturbance of the transplanted kidney has
advanced to a certain degree, hence it is urgently necessary to develop an immu-
nologically early diagnostic method that is a true reflection of the rejection (1-4).
For the past several years, we have been studying diurnal changes of macro-
phage migration inhibitory factor (MIF) after renal allografting in rats (5) and
dogs (6) by the macrophage migration inhibition test (MIT) developed by David
(7) and Bllom (8). As a results, it had become clear that MIF activity increases
prior to the appearance of acute rejection. We report here our finding that this
MIF also seems to be an effective immunologically early diagnostic method for
detecting acute renal allogaft rejection in man.
MATERIALS AND METHODS
Subjects
The subjects were seven cases of renal allograft managed in our department
during the period from March, 1974 to September, 1975 (Table 1). MIT was
conducted as a rule 2-3 times a week during the first postoperative month, twice
a week from the beginning of the second month after operation until discharge
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TABLE I. CASES OF KIDNEY TRANSPLANTATION
HLAa MLd Rejec-
Creatinine
No. Age Sex Donor clearance
match tion (mI/min.)
--_._----------_._ ..._.._~-----
-----.-.-----------
-----c--;{
LD-I 23 male mother 3 9.8% 0 92 (l y .6 m .)
LD-2 28 female 2 8.8% I died (10 m d.)
LD-3 23 male father 2 8.6% 0 89 ( 6 m d.)
LD-4 26 female mother 2 5.8% I 28 ( 5 m d.)
LD-5 32 male 3 4.1% 0 95 ( 3 m d.)
LD-6 20 female father 3 3.6% I 85 ( 2 m d.)
LD-7 25 male mother 2 4.1% 0 90 ( I m d.)
-~.._--------_.__ ._--
a Human leucocyte antigen, b mixed lymphocyte culture, c year, d month
from hospital, and once a month after discharge. For prophylactic immuno-
suppression therapy, basic treatment consisted of the oral administration of
Imuran and Medrol with 1g of Solu. Medrol being given i. v. on the first and
second postoperative days. Acute rejection was observed in three (42.8%) of the
seven cases once in each case. This was managed by pulse therapy of Solu-
Medrol and regional irradiation of 6°00 (300R/day for 3 days).
Assay of Macrophage Migration Inhibition Factor (MIF) .
MIF was measured by a modified George and Vaughan's method (9).
The preparation of donor specific antigen. Donor lymphocytes are isolated
from 50ml of heparinized peripheral blood aspirated from a donor by the
Ficoll-Oonray method and adjusted to a concentration of 5x 106 cells/ml. Four
ml of medium TO-199 is added to one ml of such lymphocyte suspension, then
ultrasonication performed for 3 min at 150 rnA, 7 9 tip. The protein concentra-
tion is measured by spectrophotometry. Ampules are filled with 0.5 ml each of
the sonicated suspension (usually 50 such ampules can be prepared), and these
ampules are kept at -20°0. At the time of use, the suspension is diluted lO-fold
and this serves as the antigen solution, having an average protein concentration
of 190 J 36,cg ml.
Preparation of sensitiud IympllO,ytes. Lymphocytes were isolated from 8 ml
of heparinized peripheral blood by the Ficoll-Conray method and suspended in
a concentration of 1 X 106 ml.
Preparation of g.lineu.-jJig I7wc'rophages. Fluid paraffin (20 ml) is injected into
the peritoneal cavity of a gJinea-pig, laparotomy performed 4 days later, and
the abdominal cavity rinsed with Hanks'solution. The rinsed solution is cen-
trifuged twice at 250g for 5 min each time, and the precipitate so obtained is
placed in TC 199 solulion, adjusted so that the number of cells contained is
2-5 X 106 cells' ml.
The macrophages and test lymphocytes are mixed in the ratio 10: 1, and the
mixed cell suspension is put under negative pressure into a hematocrit capillary
tube with one end closed. The tube is centrifuged at 250g for 5 min, then cut at
the boundary between the supernatant and the cell layer. The cell layer portion
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is placed on a round cover-glass at the bottom of MacKaness-type petri dish
(1 ml), and fixed with silicon grease. One milliliter of antigen-containing medium
is added, and this is then sealed with a cover-glass. As a control, a similar
preparation is added to the medium not containing antigen. These are then
incubated at 37°e for 24 hr. After culture, the migrations of cells around the
opening of the capillary tube are measured with a projection microscope. Test
cultures are done in triplicate. MIF activity is estimated after calculating %
migration index by the following formula.
MI (%) = _'I'1:le averagern~grat.ion area w.ith antige~ x 100
The average mIgratIOn area wIthout antIgen
A value of less than 80% is considered posi tive.
RESULTS
MIF Activity in the Non-acute Rejection Group (Fig. 1)
MIF activity (average value ± S.D. % ) throughout the entire posttransplanta-
tion course was 97.8±13.3% in LDl, 99.8±2.5% in LD3, 103.3±14.4% in
LD5, and 104.2±4.5% in LD7, indicating that there was not a single case in
which the MIF activity had become positive. The average MIF activity in these
four cases was 101.2 ± 17.2 %, which we consider as within the normal range for
MIF activity. MIF activity was near the border line of 80%, however, in 5/28 in
LDl, 1/16 in LD3, 3/15 in LD5, and 1/10 in LD7. In such cases, the assay of
MIF activity was repeated once more under careful observation of clinical symp-
toms and chemical data of blood and urine.
Results of Macrophage Inhibition Test
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Fi~. 1. Results of macrophage migration inhibition test (non-rejection group).
In the non-rejection group, MIF acti vi ty was negative after renal allografting
throughout the entire-clinical course.
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Changes of MIF Activity in the Acute Rejection Group (Fig. 2)
Acute rejection was observed once in each of LD2, LD4 and LD6. The
MIF activity prior to the rejection crisis in these three cases was 94.9 ± 18.7 %.
A false positive result was obtained in three (13.5%) of twenty-two MI tests.
Results of Macrophage Inhibition Test
(Rejection Group LD·2,4,6)
0 g
0
""
">< 08CD 0
'a
-t.!: 100 ~0c:::
.S! 00 8 8"
-ell 80 \I /lOOI- 0
'OIl
's
0
-
0 0c
-
0
c::: 50-CD
U
l-
X
Before 1 or 2 3 After
Rejection Days Days Rejection
Crisis Before After Crisis
Rejection Crisis
Fig. 2. Results of macrophage migration inhibition test (rejection group). In
the acute rejection group, MIF turned positive 1-2 days before the rejection crisis
and rapidly became negative 3 days after commencement of antirejection therapy.
If acute rejection is judged clinically by the rise in the BUN and serum
creatinine (S-Cr) level, MIF activity 1-2 days before the rejection crisis without
elevation of BUN or S-Cr was 60.4 % in LD2 (BUN 26 mg/dl, S-Cr 1.2 mg/dl),
79 % in LD4 (BUN 2:2 mg!dl, S-Cr 1mg/dl), and 63.2 % in LD6 (BUN 25 mg/dl,
S-Cr 1.2 mg/dl), showing a difinite elevation of cellular immune activity indica-
tive of the impending rejection. Thereafter, these cases were diagnosed as acute
rejection by the appearance of clinical symptoms and the elevation of BUN and
S-Cr levels. When the dose of Medrol was increased and a high dose of 1g!day
Solu-Medrol was given i. v. for three days, MIF activity decreased rapidly to a
normal range of 85 % in LD2 (BUN 102 mg/dl, S-Cr 3.5 mg/dl), 86 % in LD4
(BUN 106mg/dl, S-Cr 7.2 mg/dl) and 86% in LD6 (BUN 65 mg/dl, S-Cr 3.2
mg!dl) 3 days after the commencement of such anti-rejection therapy, in spite of
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persistent kidney insufficiency. Thereafter, MIF activity was 95.9 ± 14.9% and
no longer showed any fluctuations in cases where the transplanted kidney func-
tioned well three months after transplantation.
A brief explanation follows of the course of three typical cases that indicated
acute rejection.
Case l-LD2 (Fig. 3). A 28-year old female received her mother's kidney on
Dec. 3,1974. On the tenth post operative day (Medrol 48 mg/day, Imuran 150
mg/day) the body temperature suddenly rose to 38.1 °C, while the white blood
cell count was 8,600. Her renal function was normal with BUN 26 mg/dl and
S-Cr 1.2 mg/dl, but MIF activity turned positive to 60.4 %. On the twelfth day,
BUN lose to 83 mg/dl and S-Cr to 2.8 mg. 'dl, indicating a rejection crisis. Hence
pulse therapy with Solu-Medrol was started 1g/day for 3 days, and hemodialysis
performed twice. The renal function began to improve around the 23rd post-
transplantation day.
LD-2 (M.N.27Y)
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Fig. 3. Clinical course of LD-2. On the tenth transplantation day, body tem-
perature suddenly rose to 38.1Co, renal function was normal, but MIF activity
became positive at 60.4%. On the twelfth day, a rejection crisis was diagnosed
clinically.
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Case 2-LD4 (Fig. 4). A 26-year old female received her mother's kidney
on May 20, 1975. Despite a favorable renal function of BUN 22 mg/dl and S-Cr
1.1 mg/dl without any clinical symptoms on the 16th day after transplantation
(Medrol 48 mg/day, Imuran 150 mg/day) MIF activity became 79% which
indicated a rise in the cellular immunity. Two days later, BUN was 49 mg/dl
and S-Cr 2.7 mg/dl, a crisis was fully developed. In spite of the usual antirejec-
tion therapy, she required 8 hemodialysis over 4 weeks.
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Fig. 4. Clinical course of LD-4. On the 16th day after transplantation, MIF
turned positive to 79%. Two days later, a rejection crisis was confirmed.
Case 3-LD6 (Fig. 5). A 20-year old female received her father's kidney on
August 5, 1975. Her postoperative clinical course progressed smoothly as shown
by a BUN of 25 mg/dl and as-Cr of 1.2mg/dl on the 38th day (Medrol28mgjday
and Imuran 125 mg/day). MIF activity, however, rose to 63.0%, so she was
considered from our experience with two preceding cases to be in a state of im-
pending rejection. Pulse therapy with Solu-Medrol was, therefore, commenced.
On the following day, BUN rose to 35 mg/dl and S-Cr to 2.8 mg/dl, but her
renal function had recovered one week later.
As described above, when MIF activity is taken as a criterion, it is suggested
that MIF activity becomes positive before the rise in the concentration of BUN
and S-Cr, and that the rejection can, as in these three cases, be predicted im-
munologically one or two days before clinical diagnosis of the rejection. How-
ever, it seems that the MIF activity does not parallel the severity of the acute
rejection reaction as observed in these three cases.
6
Acta Medica Okayama, Vol. 31 [1977], Iss. 3, Art. 3
http://escholarship.lib.okayama-u.ac.jp/amo/vol31/iss3/3
MIF and Acute Renal Rejection 183
LD-6
Rejection
J
...
..
.!!
A
.
..
£
o
100
MI F
%migration 80
Index
MEDROL
(mg)
MPSS
(1g)
100
IMURAN(mg)
30~ +--t----.::::::::~:=::::==---------=:::--==
50
RENO-CAMERA 10~
Bladder
Imaging
T1me(mln) 0-1-+------------
10
CREATININE
(mg/di)
20 40 60
TIME IN DAYS
Fig. 5. Clinical course of LD-6. On the 38th transplantation day, MIF rose to
63.0% despite a good clinical course. On the following day, a rejection crisis was
confirmed clinically.
DISCUSSION
When lymphocytes isolated from animals or man showing delayed hyper-
sensitivity or cell mediated immunity are cultured with a specific corresponding
antigen, a lymp'hokine, macrophage migration inhibitory factor (MIF), is liber-
ated from the sensitized lymphocytes (10). This MIF inhibits the migration of
normal guinea-pig macrophages from capillary tubes and induces a decrease in
the radial migration area formed at the tip of a capillary tube, the so-called MI
phenomenon (7, 8). In actual practice, the MIF activity is determined by the
ratio of the migration areas (% migration index) of antigen-added, and non
antigen-added groups.
There are two migration inhibition tests, i. e. the macrophage migration in-
hibition test (MIT) where guinea-pig macrophages are used as indicator cells (7,
8), and the leucocyte migration inhibition test (LIT) where polymorphonuclear
leucocyte are used as the indicator cells, as developed by S¢borg and Bendixen
(11 ). There are no reports other than those of Turnipseed (12, 13) of MIT being
used as a parameter of rejection. The LIT uses the buffy coat of blood from
recipients, and the technique is so simple that most available reports are of LIT.
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LIT has been employed as a parameter and its efficacy in acute renal allograft re-
jection reported by Smith et at. (14), Eva Weeks and Bendixen (15), Falk et at.
(16), Dormont et at. (17), Wood et at. (18) and in liver transplantation by Eddle-
ston et at. (19). However, Rocklin et at. report the difficulty of its reproducibility
because polymorphonuclear leucocytes and sensitized lymphocytes cannot be
maintained at a certain fixed ratio in number (20). By our MIT, it is always
possible to maintain macrophages and sensitized lymphocytes in the ratio of 10 : I
(David (7) states that 5% of senstized lymphocytes would be sufficient) and it is
clinically advantageous to execute MIT with as small an amount of blood as 5m!.
The culture time required for diagnosis is generally 24 hr (7, 8), but it is said
that liberation of MIF begins by the 6th hr of culture (21) and that the diagnosis
is possible even at 8-12 hr. Generally crude or semisoluble antigen extracted
from lymphocytes (12,13,16), spleen (16-18) or kidney (14,17) is used as the
specific antigen. The most important point to be borne in mind in the execution
of MIT is the concentration of antigen to be added. If excessive antigen is added,
a non-specific inhibition of the migration of macrophages occurs, possibly leading
to misdiagnosis. There are reports in the range of 100 ,ug/ml to 2mg/ml of antigen
concentration (12-19). When crude antigen of kidney extract and spleen extract
was used, the optimal antigen concentration was 50-100,ug/mlforWood (18),
125,ug/ml for Dormont et at. (17) and 100-200 pg/ml for Weeke and Bendixen
(13). Turnipseed et at. adjusted the number of donor lymphocytes to 25 X 106
cells/ml, subjected them to freeze-thawing seven times at - 30a C, and used the
suspension as the antigen containing solution, with an optimal concentration of
1-2 mg/ml (12,13). We adjust the number of donor peripheral blood lympho-
cytes to 5 x 106 cells/ml, subject them to supersonication, and use at an optimal
concentration of 190 ± 36 fig/m!.
When LIT was used in renal transplantation, the positive rate of migration
inhibition during a rejection crisis was 100% for Wood et at. (18), 100% for Falk
et at., 95% for Dormont et at. (17), and 67% for Weeke (13). This was a marked
correlation with the rejection crisis, but the positive rate in the prerejection
period was 13.3% for Dormont et at. (17), and 16.7% for Falk et at. (16), a fairly
low percentage. The sensitivity of LIT in the early diagnosis of acute rejection
still appears to be a problem.
Direct MIT conducted periodically after renal allografting in rats, has de-
monstrated that MIF activity turns positive by the third day of transplantation,
indicating that MIT is a useful method for early immunological diagnosis of
acute rejection (5). Recently, the results of the clinical application of direct MIT
were reported for the first time by Turnipseed and Cerilli (13). They performed
MIT in 40 cases receiving kidneys from living donors, and in 16 (94.1 %) out of
17 cases showing acute rejection, the MIF activity turned positive. Moreover,
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30 % of them converted to positive MIF activity about 10 days before a distinct
clinical appearance of rejection, indicating that this method is excellent in moni-
toring cellular immunity after transplantation in both reproducibility and sensi-
tivity. An interesting finding in their report was that an accelerated rejection
occurred in two cases receiving renal allografts whose mixed lymphocyte culture
(MLC) had been negative to prospective human leucocyte antigen (HLA) identi-
cal sibling donor before operation, but whose MIF was positive. The presensiti-
zation was detected by MIT before transplantation.
The next important problem will be the effect of immunosuppressive agents
on MIF activity. Dormont et at. (17) state that Predonisolone under 0.5 mg/Kg
/day and Imuran 2-3 mg/Kg/day as a maintenance dose hardly affect MIF
activity, whereas MIF activity appears simultaneously with a rejection crisis,
Turnipseed and Cerilli (13) have reported similar results. However, recently
20-30 mg/Kg/day of Solu-Medrol as pulse therapy is being recommended by
many institutions, and it is said that the acute rejection can be suppressed in
90-95% of cases with renal allograft (22,23). Similar to Dormont's report (17),
MIF activity in our cases also turns negative within 1-3 days of the intravenous
administration of Solu-Medrol in a high dose, irrespective of functional kidney
recovery. It is not considered a suitable parameter for the follow up of acute
rejection.
As described above, we consider that MIT does reflect well the cellular
immune activation following transplantation and is a useful method for the diag-
nosis of impending rejection.
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